TRICARE 2027 Costs Mostly Stable as Oversight Scrutiny Continues
The Department of Defense says most TRICARE costs will remain largely stable in 2027, although premiums for some unsubsidized plans are expected to rise sharply. The November 9–December 8 open-enrollment period and continued scrutiny of major managed-care and pharmacy-benefit arrangements are relevant to contractors, prospective bidders, and enrollment-support providers; no new solicitation or award was identified.
Key Signals
- DoD expects most TRICARE costs to stay stable in 2027, with some unsubsidized premiums rising sharply
- TRICARE open enrollment runs November 9–December 8, 2026
- Humana Military and TriWest face continued managed-care performance and oversight scrutiny
- Congressional questions about Express Scripts add pharmacy-benefit oversight exposure
- No new TRICARE solicitation or award identified
The U.S. Department of Defense says most TRICARE costs will remain largely stable in 2027, while premiums for some unsubsidized plans are expected to rise sharply. Open enrollment is scheduled for November 9 through December 8, 2026. The available report does not specify which plans will see the largest increases or provide premium amounts, so providers advising beneficiaries should avoid treating the overall stability message as uniform across every plan. The distinction between subsidized and unsubsidized coverage is important when explaining potential changes to beneficiaries and supporting enrollment decisions.
The announcement also places consumer cost information alongside scrutiny of TRICARE’s large managed-care support arrangements. The source identifies Humana Military and TriWest Healthcare Alliance as holders of managed care support contracts valued at $136 billion. It flags performance and oversight issues involving those contracts, but does not identify a new solicitation, award, contract action, or specific performance finding. For the GovCon market, this is therefore a monitoring signal rather than an immediate bid opportunity: incumbents and prospective providers should track oversight developments and the expectations they may establish for performance documentation and accountability.
Congressional questions about Express Scripts’ pharmacy-benefit practices add a separate oversight dimension. The source does not provide the substance of those questions or describe a resulting policy, enforcement action, or procurement decision. Nevertheless, attention to pharmacy-benefit practices can matter to contractors and subcontractors operating in the broader federal health-care ecosystem, particularly where service delivery, benefit administration, transparency, and oversight intersect. Firms should distinguish this reported scrutiny from a formal requirement or announced change; the available information supports monitoring, not assumptions about an upcoming acquisition.
For contractors, the combined signal is that TRICARE remains a significant health-services market where contract performance and public accountability are receiving attention while beneficiaries prepare for plan-year cost changes. Current managed-care providers can use the reporting as a prompt to review performance records, oversight responses, and communication practices. Prospective bidders can monitor Defense Health Agency and congressional activity for any later requirements or acquisition notices, but should not infer that a recompete or new procurement has been announced. Organizations that assist beneficiaries with enrollment should communicate the November–December window and emphasize that premium effects vary by plan, especially for unsubsidized options.
- 2027 cost outlook: The Department of Defense expects most TRICARE costs to remain largely stable, with sharp premium increases anticipated for some unsubsidized plans.
- Enrollment dates: Open enrollment runs November 9–December 8, 2026; enrollment-support providers should plan communications around this period.
- Managed-care contract scale: Humana Military and TriWest Healthcare Alliance hold managed care support contracts described as worth $136 billion.
- Oversight signal: The report highlights performance and oversight issues involving the managed-care support contracts but supplies no specific findings or corrective actions.
- Pharmacy-benefit scrutiny: Congress has raised questions about Express Scripts’ pharmacy-benefit practices; no resulting procurement or policy action is identified.
- No immediate acquisition: The source identifies no new solicitation or award, so this item is market and oversight intelligence rather than a bid notice.
- Incumbent action: Current providers should maintain clear evidence of performance, accountability, and responsiveness to oversight.
- Bidder action: Prospective managed-care providers should monitor agency and congressional developments without assuming a new competition has been announced.
- Beneficiary communications: Explain that cost changes vary by plan and that the report does not specify exact premium increases or affected plan names.
Agencies
- U.S. Department of Defense
- Defense Health Agency
- Congress
Vendors
- Humana Military
- TriWest Healthcare Alliance
- Express Scripts
Sources
- TRICARE costs remain mostly stable in 2027, but some premiums spike - Federal News NetworkFederal News Network · Nov 07